Esya's DNA probes can ratiometrically quantify ions within endocytic organelles such as Endosomes & Lysosomes, for diseases such as COVID-19, Lysosomal Storage Disorders & Alzheimer's Disease. We are a precision biomarker company providing groundbreaking molecular insights to facilitate drug discovery, diagnostics, and personalized medicine, by profiling ion signatures within key organelles. By chemically profiling various biological markers, such as lysosomal ion signatures, our technologies can help decode the underpinnings of a number of different diseases, as well as test potential drug treatments and therapies.
